Back to 
Hood River Capital Management LLC
Hood River Capital Management LLC
SNDX3 quarters
Position history for Hood River Capital Management LLC's holdings in SYNDAX PHARMACEUTICALS INC
Yes. Hood River Capital Management holds 2,564,279 shares of SNDX (Syndax Pharmaceuticals), worth $56.1M, as of its Q2 2026 13F filing. It increased the position by 209,994 shares (+8.9%) from Q1 2026. Hood River Capital Management has held SNDX since Q4 2025, across 3 quarterly 13F filings. SNDX is 0.4% of Hood River Capital Management's reported 13F portfolio.
Current Value
$56.1M
Current Shares
2.6M
Total Value Change
+$7.4M
Total Shares Change
+247,726
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., BlackRock Finance, Inc.